Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06121869 · ClinicalTrials.gov registry record · NA
Dileucine and Resistance Training Adaptations
A NA study of Hypertrophy and Strength Training Adaptations, sponsored by Lindenwood University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT06121869: Completed NA study of Hypertrophy and Strength Training Adaptations, sponsored by Lindenwood University.
NCT06121869 is a NA study of Hypertrophy and Strength Training Adaptations that has completed, run by Lindenwood University. The registered enrollment target is 34 participants, above the 30-participant average among 4 other Hypertrophy trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06121869, a NA study of Hypertrophy and Strength Training Adaptations, has completed, sponsored by Lindenwood University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to compare the observed changes in resistance training adaptations after supplementation of isomolar amounts of leucine or dileucine in healthy resistance-trained men. This will provide a better understanding of supplementation with leucine versus dileucine over a 10-week period in regards to increasing muscular performance.
Primary Outcome
Fat-free mass will be determined via Dual-Energy X-Ray Absorptiometry
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Leucine
- DIETARY_SUPPLEMENT Dileucine
Study Locations (1)
Missouri
- Exercise and Performance Nutrition Laboratory - Saint Charles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-05-07 |
| Est. Completion | 2023-06-29 |
| Phase | NA |
What the finished NCT06121869 record still lists
NCT06121869 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, above the 30-participant average among 4 other Hypertrophy trials with a reported enrollment target (13% higher).
The record links to 3 conditions, with Hypertrophy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06121869 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06121869 about?
NCT06121869 is a clinical study titled "Dileucine and Resistance Training Adaptations". This study seeks to compare the observed changes in resistance training adaptations after supplementation of isomolar amounts of leucine or dileucine in healthy resistance-trained men. This will provide a better understanding of supplementation with leucine versus dileucine over a 10-week period in ...
What is the current status of trial NCT06121869?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2021-05-07. Estimated completion is 2023-06-29.
What conditions does trial NCT06121869 study?
This clinical trial studies the following conditions: Hypertrophy, Strength Training Adaptations, Weight-Bearing Strengthening Program.
What interventions are being tested in trial NCT06121869?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Leucine (DIETARY_SUPPLEMENT), Dileucine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06121869?
This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06121869 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BFR and Muscle Mitochondrial Oxidative Capacity
COMPLETED · NA
-
Protein Ingestion Timing on Body Composition and Biochemical Markers in Resistance-trained Males
COMPLETED · NA
-
Egg Consumption and Muscular Adaptations
COMPLETED · NA
-
Effect of Daily Doses of Rice or Whey Protein on Resistance Training Adaptations
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI